SCHEMBL18308807

SCHEMBL18308807

Cc1cc(CP)ccc1-c1ccc(C)c(-c2cc(CP)cc(CP)c2)c1

nearest known ligand 0.41

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ HTR7 P34969 2/20 0.33
▸ ESR1 P03372 1/20 0.33
▸ ESR2 Q92731 1/20 0.33
▸ RARB P10826 1/20 0.31
▸ AKR1C3 P42330 1/20 0.30
▸ AKR1C2 P52895 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18308816 0.85 RXRA (0.32) RARB
SCHEMBL18308802 0.84 ESR1 (0.32) ESR1ESR2
SCHEMBL18308805 0.82 HTR7 (0.41) HTR7ESR1ESR2AKR1C3AKR1C2
SCHEMBL18308817 0.81 FYN (0.33) —
SCHEMBL26032092 0.81 RARB (0.39) ESR1ESR2RARB
SCHEMBL18308744 0.76 ESR2 (0.32) HTR7ESR1ESR2
SCHEMBL18308735 0.76 RARB (0.36) ESR1ESR2RARB
SCHEMBL18308773 0.75 ESR1 (0.31) ESR1ESR2
SCHEMBL18806017 0.75 — —
SCHEMBL18308766 0.75 ESR1 (0.31) ESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11718791-B2 Polymerisable compounds and the use thereof in liquid-crystal displays MERCK PATENT GMBH (DE) 2023-08-08 — — US disclosed
US-20170121606-A1 POLYMERIZABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS GMBH, MERCK PATENT (DE) 2017-05-04 — — US disclosed
US-20160362606-A1 POLYMERIZABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS MERCK PATENT GMBH (DE) 2016-12-15 — — US disclosed
US-20150221879-A1 Organometallic Complex, Composition and Light Emitting Element Including the Organometallic Complex SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2015-08-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11718791-B2 Polymerisable compounds and the use thereof in liquid-crystal displays VCL, ILK, LCP1 HTR7 4174/4885ESR1 2744/4885ESR2 4146/4885
US-20150221879-A1 Organometallic Complex, Composition and Light Emitting Element Including the Organometallic Complex PPOX, RPL15, LAGE3 HTR7 3544/4885ESR1 2747/4885ESR2 2456/4885
US-20170121606-A1 POLYMERIZABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS VCL, LCP1, MAP1LC3C HTR7 3960/4885ESR1 2626/4885ESR2 4322/4885
US-20160362606-A1 POLYMERIZABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS VCL, PLEC, EML4 HTR7 4122/4885ESR1 3527/4885ESR2 4381/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback